Sural nerve fibre pathology in diabetic patients with mild neuropathy

Relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology

Rayaz Malik, A. Veves, D. Walker, I. Siddique, R. H. Lye, W. Schady, A. J M Boulton

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Nerve fibre pathology is poorly described in diabetic patients with mild neuropathy and has not been adequately related to clinical evaluation, quantitative sensory examination and neurophysiology. Sural nerve myelinated and unmyelinated fibre pathology was morphometrically quantified and related to the presence of pain and conventional measures of neuropathic severity in 15 diabetic patients with mild neuropathy and 14 control subjects. Diabetic patients demonstrated a significant (P<0.01) reduction in myelinated fibre density, but no change in fibre/axonal area, or g-ratio, compared to control subjects. Unmyelinated fibre degeneration was evidenced by an increase in the percentage of unassociated Schwann cell profiles (P<0.0001) and a reduction in axon density (P<0.0008) in diabetic patients. This was associated with a significant reduction in unmyelinated axon diameter (P<0.001) with a shift of the size frequency distribution to the left (P<0.02). Neurophysiology, quantitative sensory testing and nerve fibre pathology failed to differentiate diabetic patients with painful and painless neuropathy and failed to correlate with any measure of unmyelinated fibre pathology.

Original languageEnglish
Pages (from-to)367-374
Number of pages8
JournalActa Neuropathologica
Volume101
Issue number4
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Sural Nerve
Electrophysiology
Peripheral Nerves
Nerve Fibers
Pathology
Pain
Neurophysiology
Axons
Schwann Cells

Keywords

  • Axonal atrophy
  • Diabetic neuropathy
  • Pain
  • Unmyelinated fibre

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Sural nerve fibre pathology in diabetic patients with mild neuropathy : Relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. / Malik, Rayaz; Veves, A.; Walker, D.; Siddique, I.; Lye, R. H.; Schady, W.; Boulton, A. J M.

In: Acta Neuropathologica, Vol. 101, No. 4, 2001, p. 367-374.

Research output: Contribution to journalArticle

Malik, Rayaz ; Veves, A. ; Walker, D. ; Siddique, I. ; Lye, R. H. ; Schady, W. ; Boulton, A. J M. / Sural nerve fibre pathology in diabetic patients with mild neuropathy : Relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. In: Acta Neuropathologica. 2001 ; Vol. 101, No. 4. pp. 367-374.
@article{5d81b1d40df84626835b508e48186b70,
title = "Sural nerve fibre pathology in diabetic patients with mild neuropathy: Relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology",
abstract = "Nerve fibre pathology is poorly described in diabetic patients with mild neuropathy and has not been adequately related to clinical evaluation, quantitative sensory examination and neurophysiology. Sural nerve myelinated and unmyelinated fibre pathology was morphometrically quantified and related to the presence of pain and conventional measures of neuropathic severity in 15 diabetic patients with mild neuropathy and 14 control subjects. Diabetic patients demonstrated a significant (P<0.01) reduction in myelinated fibre density, but no change in fibre/axonal area, or g-ratio, compared to control subjects. Unmyelinated fibre degeneration was evidenced by an increase in the percentage of unassociated Schwann cell profiles (P<0.0001) and a reduction in axon density (P<0.0008) in diabetic patients. This was associated with a significant reduction in unmyelinated axon diameter (P<0.001) with a shift of the size frequency distribution to the left (P<0.02). Neurophysiology, quantitative sensory testing and nerve fibre pathology failed to differentiate diabetic patients with painful and painless neuropathy and failed to correlate with any measure of unmyelinated fibre pathology.",
keywords = "Axonal atrophy, Diabetic neuropathy, Pain, Unmyelinated fibre",
author = "Rayaz Malik and A. Veves and D. Walker and I. Siddique and Lye, {R. H.} and W. Schady and Boulton, {A. J M}",
year = "2001",
doi = "10.1007/s004010000287",
language = "English",
volume = "101",
pages = "367--374",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Sural nerve fibre pathology in diabetic patients with mild neuropathy

T2 - Relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology

AU - Malik, Rayaz

AU - Veves, A.

AU - Walker, D.

AU - Siddique, I.

AU - Lye, R. H.

AU - Schady, W.

AU - Boulton, A. J M

PY - 2001

Y1 - 2001

N2 - Nerve fibre pathology is poorly described in diabetic patients with mild neuropathy and has not been adequately related to clinical evaluation, quantitative sensory examination and neurophysiology. Sural nerve myelinated and unmyelinated fibre pathology was morphometrically quantified and related to the presence of pain and conventional measures of neuropathic severity in 15 diabetic patients with mild neuropathy and 14 control subjects. Diabetic patients demonstrated a significant (P<0.01) reduction in myelinated fibre density, but no change in fibre/axonal area, or g-ratio, compared to control subjects. Unmyelinated fibre degeneration was evidenced by an increase in the percentage of unassociated Schwann cell profiles (P<0.0001) and a reduction in axon density (P<0.0008) in diabetic patients. This was associated with a significant reduction in unmyelinated axon diameter (P<0.001) with a shift of the size frequency distribution to the left (P<0.02). Neurophysiology, quantitative sensory testing and nerve fibre pathology failed to differentiate diabetic patients with painful and painless neuropathy and failed to correlate with any measure of unmyelinated fibre pathology.

AB - Nerve fibre pathology is poorly described in diabetic patients with mild neuropathy and has not been adequately related to clinical evaluation, quantitative sensory examination and neurophysiology. Sural nerve myelinated and unmyelinated fibre pathology was morphometrically quantified and related to the presence of pain and conventional measures of neuropathic severity in 15 diabetic patients with mild neuropathy and 14 control subjects. Diabetic patients demonstrated a significant (P<0.01) reduction in myelinated fibre density, but no change in fibre/axonal area, or g-ratio, compared to control subjects. Unmyelinated fibre degeneration was evidenced by an increase in the percentage of unassociated Schwann cell profiles (P<0.0001) and a reduction in axon density (P<0.0008) in diabetic patients. This was associated with a significant reduction in unmyelinated axon diameter (P<0.001) with a shift of the size frequency distribution to the left (P<0.02). Neurophysiology, quantitative sensory testing and nerve fibre pathology failed to differentiate diabetic patients with painful and painless neuropathy and failed to correlate with any measure of unmyelinated fibre pathology.

KW - Axonal atrophy

KW - Diabetic neuropathy

KW - Pain

KW - Unmyelinated fibre

UR - http://www.scopus.com/inward/record.url?scp=0035035118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035035118&partnerID=8YFLogxK

U2 - 10.1007/s004010000287

DO - 10.1007/s004010000287

M3 - Article

VL - 101

SP - 367

EP - 374

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 4

ER -